GB2391865B - Improvements in the extraction of pharmaceutically active components from plant materials - Google Patents

Improvements in the extraction of pharmaceutically active components from plant materials

Info

Publication number
GB2391865B
GB2391865B GB0218901A GB0218901A GB2391865B GB 2391865 B GB2391865 B GB 2391865B GB 0218901 A GB0218901 A GB 0218901A GB 0218901 A GB0218901 A GB 0218901A GB 2391865 B GB2391865 B GB 2391865B
Authority
GB
United Kingdom
Prior art keywords
extraction
pharmaceutically active
active components
plant materials
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB0218901A
Other versions
GB0218901D0 (en
GB2391865A (en
Inventor
Brian Anthony Whittle
Colin Anthony Hill
Ian Ronald Flockhart
David Victor Downs
Peter Gibson
Gary William Wheatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Pharma Ltd
Original Assignee
GW Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Pharma Ltd filed Critical GW Pharma Ltd
Priority to GB0218901A priority Critical patent/GB2391865B/en
Publication of GB0218901D0 publication Critical patent/GB0218901D0/en
Priority to CN038242117A priority patent/CN1691954B/en
Priority to PT101804649T priority patent/PT2311475T/en
Priority to MXPA05001621A priority patent/MXPA05001621A/en
Priority to KR1020057002527A priority patent/KR101113162B1/en
Priority to JP2004528675A priority patent/JP4657716B2/en
Priority to SI200332204T priority patent/SI1536810T1/en
Priority to CA2823474A priority patent/CA2823474A1/en
Priority to CA2994322A priority patent/CA2994322A1/en
Priority to PL388837A priority patent/PL226646B1/en
Priority to PT03787897T priority patent/PT1536810E/en
Priority to DK10180464.9T priority patent/DK2311475T3/en
Priority to CA2455129A priority patent/CA2455129C/en
Priority to AU2003253002A priority patent/AU2003253002B2/en
Priority to PL375357A priority patent/PL205945B1/en
Priority to ES03787897T priority patent/ES2392510T3/en
Priority to DK03787897.2T priority patent/DK1536810T3/en
Priority to ES10180464.9T priority patent/ES2592531T3/en
Priority to EP10180464.9A priority patent/EP2311475B1/en
Priority to DE10337458A priority patent/DE10337458B4/en
Priority to PCT/GB2003/003566 priority patent/WO2004016277A2/en
Priority to EP03787897A priority patent/EP1536810B1/en
Publication of GB2391865A publication Critical patent/GB2391865A/en
Priority to ZA200501169A priority patent/ZA200501169B/en
Application granted granted Critical
Publication of GB2391865B publication Critical patent/GB2391865B/en
Priority to HK05110252.7A priority patent/HK1076249A1/en
Priority to JP2010149763A priority patent/JP5235206B2/en
Priority to CY20121101035T priority patent/CY1113375T1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
GB0218901A 2002-08-14 2002-08-14 Improvements in the extraction of pharmaceutically active components from plant materials Expired - Lifetime GB2391865B (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GB0218901A GB2391865B (en) 2002-08-14 2002-08-14 Improvements in the extraction of pharmaceutically active components from plant materials
PL375357A PL205945B1 (en) 2002-08-14 2003-08-14 Improved EXTRACTION OF PHARMACEUTICALLY ACTIVE CANNABINOIDS FROM PLANT MATERIALS
DK03787897.2T DK1536810T3 (en) 2002-08-14 2003-08-14 EXTRACTION OF PHARMACEUTICAL ACTIVE CANNABINOIDS FROM PLANT MATERIALS
PT101804649T PT2311475T (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
KR1020057002527A KR101113162B1 (en) 2002-08-14 2003-08-14 Improvements in the extraction of pharmaceutically active components from plant materials
JP2004528675A JP4657716B2 (en) 2002-08-14 2003-08-14 Improved extraction of pharmaceutically active ingredients from plant material
SI200332204T SI1536810T1 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
CA2823474A CA2823474A1 (en) 2002-08-14 2003-08-14 Botanical drug substances comprising various proportions of thc and cbd
CA2994322A CA2994322A1 (en) 2002-08-14 2003-08-14 Botanical drug substances comprising various proportions of thc and cbd
PL388837A PL226646B1 (en) 2002-08-14 2003-08-14 Botanical drug substance
PT03787897T PT1536810E (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
DK10180464.9T DK2311475T3 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids FROM PLANT MATERIALS
CA2455129A CA2455129C (en) 2002-08-14 2003-08-14 Improvements in the extraction of pharmaceutically active components from plant materials
AU2003253002A AU2003253002B2 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
CN038242117A CN1691954B (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
ES03787897T ES2392510T3 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
MXPA05001621A MXPA05001621A (en) 2002-08-14 2003-08-14 Improvements in the extraction of pharmaceutically active components from plant materials.
ES10180464.9T ES2592531T3 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
EP10180464.9A EP2311475B1 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
DE10337458A DE10337458B4 (en) 2002-08-14 2003-08-14 Improvements in the extraction of pharmaceutically active components from plant materials
PCT/GB2003/003566 WO2004016277A2 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
EP03787897A EP1536810B1 (en) 2002-08-14 2003-08-14 Extraction of pharmaceutically active cannabinoids from plant materials
ZA200501169A ZA200501169B (en) 2002-08-14 2005-02-09 Extraction of pharmaceutically active cannabinoids from plant materials
HK05110252.7A HK1076249A1 (en) 2002-08-14 2005-11-16 Extraction of pharmaceutically active cannabinoids from plant materials
JP2010149763A JP5235206B2 (en) 2002-08-14 2010-06-30 Improved extraction of pharmaceutically active ingredients from plant material
CY20121101035T CY1113375T1 (en) 2002-08-14 2012-10-30 EXTRACTION OF PHARMACEUTICAL ACTIVE CANNIVES FROM HERBAL MATERIALS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0218901A GB2391865B (en) 2002-08-14 2002-08-14 Improvements in the extraction of pharmaceutically active components from plant materials

Publications (3)

Publication Number Publication Date
GB0218901D0 GB0218901D0 (en) 2002-09-25
GB2391865A GB2391865A (en) 2004-02-18
GB2391865B true GB2391865B (en) 2005-06-01

Family

ID=9942303

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0218901A Expired - Lifetime GB2391865B (en) 2002-08-14 2002-08-14 Improvements in the extraction of pharmaceutically active components from plant materials

Country Status (2)

Country Link
GB (1) GB2391865B (en)
ZA (1) ZA200501169B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400320B (en) * 2001-05-04 2005-06-08 Gw Pharma Ltd Cannabinoid-rich extracts
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
GB2439393B (en) * 2006-06-23 2011-05-11 Gw Pharma Ltd Cannabinoids for use in the treatment of neuropathic pain
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
GB2524689B (en) 2011-05-20 2016-01-27 Gw Pharma Ltd Cannabinoids for use in the treatment of neuropathic pain
GB201111261D0 (en) 2011-07-01 2011-08-17 Gw Pharma Ltd Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
GB2516814B (en) 2013-06-19 2016-08-31 Otsuka Pharma Co Ltd Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
US9259449B2 (en) * 2014-01-07 2016-02-16 Joshua Michael Raderman Method for modifying THC content in a lipid-based extract of cannabis
US10143706B2 (en) 2016-06-29 2018-12-04 Cannscience Innovations, Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation
WO2018071452A1 (en) * 2016-10-11 2018-04-19 Growblox Life Sciences L.L.C. Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279824A (en) * 1979-11-01 1981-07-21 Mckinney Laurence O Method and apparatus for processing herbaceous plant materials including the plant cannabis
JPS60120957A (en) * 1983-12-06 1985-06-28 Japan Tobacco Inc Preparation of essence of beefsteak plant
BR9006096A (en) * 1990-11-30 1992-07-14 Unicamp PROCESS AND EQUIPMENT FOR SUBCRITICAL EXTRACTION
EP0721980A2 (en) * 1994-12-17 1996-07-17 SKW Trostberg Aktiengesellschaft Process for the selective extraction of fats and/or oils from solid naturel substances
US6365416B1 (en) * 1998-10-26 2002-04-02 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
WO2002032420A1 (en) * 2000-10-17 2002-04-25 Delta-9-Pharma Gmbh Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
WO2002064109A2 (en) * 2001-02-14 2002-08-22 Gw Pharma Limited Mucoadhesive pharmaceutical formulations
WO2003061563A2 (en) * 2001-12-04 2003-07-31 University Of Mississippi Method of preparing delta-9 tetrahydrocannabinol
WO2003064407A2 (en) * 2002-02-01 2003-08-07 Resolution Chemicals Limited Production of δ9 tetrahydrocannabinol
WO2003063847A1 (en) * 2002-02-01 2003-08-07 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279824A (en) * 1979-11-01 1981-07-21 Mckinney Laurence O Method and apparatus for processing herbaceous plant materials including the plant cannabis
JPS60120957A (en) * 1983-12-06 1985-06-28 Japan Tobacco Inc Preparation of essence of beefsteak plant
BR9006096A (en) * 1990-11-30 1992-07-14 Unicamp PROCESS AND EQUIPMENT FOR SUBCRITICAL EXTRACTION
EP0721980A2 (en) * 1994-12-17 1996-07-17 SKW Trostberg Aktiengesellschaft Process for the selective extraction of fats and/or oils from solid naturel substances
US6365416B1 (en) * 1998-10-26 2002-04-02 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
WO2002032420A1 (en) * 2000-10-17 2002-04-25 Delta-9-Pharma Gmbh Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
WO2002064109A2 (en) * 2001-02-14 2002-08-22 Gw Pharma Limited Mucoadhesive pharmaceutical formulations
WO2003061563A2 (en) * 2001-12-04 2003-07-31 University Of Mississippi Method of preparing delta-9 tetrahydrocannabinol
WO2003064407A2 (en) * 2002-02-01 2003-08-07 Resolution Chemicals Limited Production of δ9 tetrahydrocannabinol
WO2003063847A1 (en) * 2002-02-01 2003-08-07 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
http://www.drugslibrary.org/olsen/HEMP/IHA/jiha5113.html-(PATE) *
http://www.punks.host.sk/hashoil.html-Hash oil at home *
Sigma-Aldrich product numbers: T2511, T4889, T2386, T4764 and C6395 *
WPI abstract AN-1992-276857 [34] of BR 9006096 A (UNICAMP) *

Also Published As

Publication number Publication date
ZA200501169B (en) 2006-12-27
GB0218901D0 (en) 2002-09-25
GB2391865A (en) 2004-02-18

Similar Documents

Publication Publication Date Title
HK1076249A1 (en) Extraction of pharmaceutically active cannabinoids from plant materials
PT1478339E (en) Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
GB0210397D0 (en) Pharmaceutical formulations
EP1552833A4 (en) Stable solid preparations
ZA200502496B (en) Ester compound and medicinal use thereof.
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
EP1469840A4 (en) Cyclosporin-containing sustained release pharmaceutical composition
PL373806A1 (en) Novel physiolgically active substances
ZA200501169B (en) Extraction of pharmaceutically active cannabinoids from plant materials
IL175499A (en) Detoxified pneumococcal neuraminidase and pharmaceutical compositions containing the same
EP1548121A4 (en) Novel physiologically active substances
AU2003290685A8 (en) Active fasteners
HUP0303948A2 (en) Solid orally-dispersible pharmaceutical formulation
GB2392093B (en) Pharmaceutical formulations
IL169163A0 (en) Optically active dihydropyridine derivative and pharmaceutical compositions containing the same
GB0205347D0 (en) Biologically active complex
AU2003216267A8 (en) Plant preparations
HUP0203310A3 (en) Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof
AU2003281698A8 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
GB9917505D0 (en) Extraction of materials from plants
GB0211145D0 (en) Herbal formulations
GB0203227D0 (en) Lightning shelters
GB0211606D0 (en) Plant shelter
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20220813